4//SEC Filing
RUPP RANDALL 4
Accession 0001237899-04-000043
CIK 0000872589other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 10:53 AM ET
Size
8.5 KB
Accession
0001237899-04-000043
Insider Transaction Report
Form 4
RUPP RANDALL
SVP, Manuf & Process Sciences
Transactions
- Sale
Common Stock
2004-10-14$7.33/sh−10,000$73,270→ 11,391 total - Exercise/Conversion
Common Stock
2004-10-14$4.25/sh+10,000$42,500→ 21,391 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2004-10-14−10,000→ 10,000 totalExercise: $4.25Exp: 2004-10-17→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]An exercise date, exercise price, puchase price, sales price and expiration date are not applicable in this case.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001226688
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 10:53 AM ET
- Size
- 8.5 KB